Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypoparathyroidism | 24 | 2023 | 120 | 7.360 |
Why?
|
Parathyroid Hormone | 29 | 2024 | 1800 | 3.640 |
Why?
|
Parathyroid Glands | 7 | 2024 | 509 | 1.910 |
Why?
|
Hypocalcemia | 6 | 2018 | 191 | 1.730 |
Why?
|
Hormone Replacement Therapy | 8 | 2021 | 745 | 1.300 |
Why?
|
Hyperparathyroidism, Primary | 6 | 2022 | 160 | 1.250 |
Why?
|
Calcium | 21 | 2024 | 5755 | 1.090 |
Why?
|
Diphtheria Toxin | 2 | 2017 | 255 | 1.050 |
Why?
|
Hypercalciuria | 2 | 2017 | 31 | 1.020 |
Why?
|
GTP-Binding Protein alpha Subunits | 2 | 2017 | 100 | 0.990 |
Why?
|
Phosphates | 7 | 2023 | 785 | 0.830 |
Why?
|
Hyperphosphatemia | 2 | 2017 | 40 | 0.700 |
Why?
|
Parathyroidectomy | 4 | 2017 | 235 | 0.690 |
Why?
|
Vitamin D | 13 | 2023 | 3224 | 0.660 |
Why?
|
Recombinant Proteins | 8 | 2021 | 6621 | 0.620 |
Why?
|
Periodicals as Topic | 2 | 2018 | 1431 | 0.570 |
Why?
|
Naphthalenes | 1 | 2017 | 194 | 0.550 |
Why?
|
Databases as Topic | 1 | 2018 | 475 | 0.540 |
Why?
|
Peptides, Cyclic | 2 | 2017 | 400 | 0.520 |
Why?
|
Receptors, Parathyroid Hormone | 5 | 1999 | 332 | 0.510 |
Why?
|
Hypophosphatemia, Familial | 2 | 2012 | 34 | 0.480 |
Why?
|
Calcitriol | 5 | 2022 | 297 | 0.470 |
Why?
|
Osteogenesis Imperfecta | 1 | 2014 | 83 | 0.460 |
Why?
|
Fibrous Dysplasia, Polyostotic | 2 | 2024 | 36 | 0.460 |
Why?
|
Hajdu-Cheney Syndrome | 1 | 2013 | 2 | 0.460 |
Why?
|
Editorial Policies | 1 | 2018 | 451 | 0.440 |
Why?
|
Glucose Transporter Type 2 | 1 | 2012 | 62 | 0.430 |
Why?
|
Receptor, Notch2 | 1 | 2013 | 89 | 0.430 |
Why?
|
Fanconi Syndrome | 1 | 2012 | 35 | 0.420 |
Why?
|
Rickets | 1 | 2012 | 74 | 0.410 |
Why?
|
Collagen Type I | 1 | 2014 | 592 | 0.390 |
Why?
|
Fibroblast Growth Factors | 6 | 2023 | 878 | 0.380 |
Why?
|
Osteomalacia | 3 | 2008 | 53 | 0.380 |
Why?
|
Genes, Dominant | 3 | 2013 | 880 | 0.370 |
Why?
|
Parathyroid Neoplasms | 1 | 2011 | 245 | 0.350 |
Why?
|
Information Dissemination | 1 | 2018 | 1099 | 0.350 |
Why?
|
Gene Deletion | 2 | 2014 | 2751 | 0.320 |
Why?
|
Osteoporosis | 3 | 2017 | 1579 | 0.320 |
Why?
|
Germ-Line Mutation | 2 | 2013 | 1788 | 0.310 |
Why?
|
Fractures, Bone | 2 | 2023 | 1947 | 0.310 |
Why?
|
Parathyroid Hormone-Related Protein | 3 | 2015 | 331 | 0.300 |
Why?
|
Receptors, G-Protein-Coupled | 4 | 2022 | 1222 | 0.290 |
Why?
|
Nuclear Proteins | 3 | 2012 | 5856 | 0.290 |
Why?
|
Pedigree | 7 | 2014 | 4642 | 0.270 |
Why?
|
25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 2 | 2023 | 61 | 0.270 |
Why?
|
Fascioliasis | 2 | 2000 | 14 | 0.240 |
Why?
|
Mutation | 6 | 2017 | 29786 | 0.240 |
Why?
|
Fasciola hepatica | 2 | 2000 | 15 | 0.240 |
Why?
|
Transcription Factors | 4 | 2014 | 12207 | 0.240 |
Why?
|
Bone Density Conservation Agents | 2 | 2023 | 772 | 0.230 |
Why?
|
Fibrous Dysplasia of Bone | 1 | 2024 | 54 | 0.230 |
Why?
|
Disease Models, Animal | 3 | 2017 | 18034 | 0.230 |
Why?
|
Bone and Bones | 5 | 2023 | 2576 | 0.230 |
Why?
|
Amiloride | 1 | 2022 | 121 | 0.220 |
Why?
|
Renal Insufficiency, Chronic | 4 | 2023 | 2200 | 0.210 |
Why?
|
Homeostasis | 5 | 2023 | 3339 | 0.210 |
Why?
|
Hyperparathyroidism | 3 | 2018 | 339 | 0.200 |
Why?
|
Urolithiasis | 1 | 2022 | 132 | 0.190 |
Why?
|
Endocrine System Diseases | 1 | 2023 | 248 | 0.190 |
Why?
|
Anthelmintics | 1 | 2000 | 62 | 0.180 |
Why?
|
Adenoma | 1 | 2011 | 2174 | 0.180 |
Why?
|
Homozygote | 2 | 2015 | 1787 | 0.180 |
Why?
|
Calcium, Dietary | 2 | 2019 | 526 | 0.170 |
Why?
|
Minerals | 1 | 2021 | 275 | 0.170 |
Why?
|
Receptors, Calcium-Sensing | 2 | 2018 | 315 | 0.170 |
Why?
|
Humans | 57 | 2024 | 744366 | 0.170 |
Why?
|
Thyroidectomy | 3 | 2023 | 879 | 0.160 |
Why?
|
Mice, Transgenic | 3 | 2017 | 9735 | 0.160 |
Why?
|
Chromogranins | 1 | 2019 | 160 | 0.160 |
Why?
|
Hypercalcemia | 2 | 2018 | 409 | 0.160 |
Why?
|
Animals | 25 | 2024 | 168768 | 0.150 |
Why?
|
Receptor, Parathyroid Hormone, Type 1 | 6 | 2017 | 307 | 0.150 |
Why?
|
Puberty, Precocious | 1 | 2019 | 156 | 0.150 |
Why?
|
Cholestasis | 1 | 2000 | 378 | 0.150 |
Why?
|
Neuralgia | 1 | 2024 | 570 | 0.150 |
Why?
|
DNA Mutational Analysis | 5 | 2019 | 4185 | 0.150 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2019 | 199 | 0.150 |
Why?
|
Male | 30 | 2022 | 350115 | 0.150 |
Why?
|
Poisons | 1 | 2017 | 34 | 0.140 |
Why?
|
Luminescent Agents | 1 | 2017 | 54 | 0.140 |
Why?
|
Glucuronidase | 1 | 2018 | 207 | 0.140 |
Why?
|
Female | 30 | 2022 | 380193 | 0.140 |
Why?
|
Kidney | 9 | 2023 | 7184 | 0.140 |
Why?
|
Hyponatremia | 1 | 2019 | 298 | 0.140 |
Why?
|
Depsipeptides | 1 | 2016 | 94 | 0.140 |
Why?
|
Gene Knock-In Techniques | 1 | 2017 | 418 | 0.130 |
Why?
|
Mutation, Missense | 2 | 2015 | 2566 | 0.130 |
Why?
|
Benzimidazoles | 1 | 2000 | 850 | 0.130 |
Why?
|
Mesenchymoma | 2 | 2008 | 47 | 0.130 |
Why?
|
Diabetes Insipidus, Neurogenic | 1 | 2014 | 19 | 0.130 |
Why?
|
Authorship | 1 | 2018 | 271 | 0.130 |
Why?
|
Peer Review, Research | 1 | 2018 | 329 | 0.120 |
Why?
|
Bradykinin | 1 | 1995 | 214 | 0.120 |
Why?
|
Acrylic Resins | 1 | 1995 | 142 | 0.120 |
Why?
|
Calcium Citrate | 1 | 2013 | 6 | 0.120 |
Why?
|
Uremia | 4 | 1996 | 200 | 0.120 |
Why?
|
Adult | 16 | 2021 | 214052 | 0.120 |
Why?
|
Mice | 9 | 2023 | 81201 | 0.110 |
Why?
|
Renal Dialysis | 3 | 2008 | 1783 | 0.110 |
Why?
|
Pseudohypoparathyroidism | 3 | 2019 | 87 | 0.110 |
Why?
|
Middle Aged | 17 | 2021 | 213390 | 0.110 |
Why?
|
Molecular Sequence Data | 7 | 2012 | 18111 | 0.110 |
Why?
|
Spasm | 1 | 2013 | 121 | 0.110 |
Why?
|
Double-Blind Method | 3 | 2018 | 12025 | 0.110 |
Why?
|
Amino Acid Sequence | 4 | 2012 | 13814 | 0.110 |
Why?
|
Sodium-Phosphate Cotransporter Proteins, Type IIc | 1 | 2012 | 15 | 0.110 |
Why?
|
Lanthanum | 1 | 2012 | 30 | 0.110 |
Why?
|
Finger Phalanges | 1 | 2013 | 38 | 0.110 |
Why?
|
Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2012 | 44 | 0.110 |
Why?
|
Genetic Diseases, Inborn | 1 | 1997 | 587 | 0.110 |
Why?
|
HEK293 Cells | 3 | 2017 | 4208 | 0.110 |
Why?
|
Delayed-Action Preparations | 1 | 2016 | 968 | 0.100 |
Why?
|
Chromatin | 1 | 2024 | 2933 | 0.100 |
Why?
|
Injections, Subcutaneous | 1 | 2013 | 667 | 0.100 |
Why?
|
Glucose Transporter Type 1 | 1 | 2012 | 193 | 0.100 |
Why?
|
Polyamines | 1 | 2012 | 120 | 0.100 |
Why?
|
Sequence Analysis, DNA | 2 | 2013 | 4805 | 0.100 |
Why?
|
Acetates | 1 | 2012 | 311 | 0.100 |
Why?
|
Chelating Agents | 1 | 2012 | 380 | 0.090 |
Why?
|
Heterozygote | 2 | 2019 | 2804 | 0.090 |
Why?
|
Reference Values | 1 | 2018 | 4982 | 0.090 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 3646 | 0.090 |
Why?
|
Europe | 1 | 2017 | 3338 | 0.090 |
Why?
|
Family Health | 2 | 2012 | 1281 | 0.090 |
Why?
|
Tissue Extracts | 2 | 2008 | 135 | 0.090 |
Why?
|
Kidney Tubules, Proximal | 1 | 2012 | 416 | 0.090 |
Why?
|
Green Fluorescent Proteins | 1 | 2016 | 2088 | 0.090 |
Why?
|
Hyperparathyroidism, Secondary | 2 | 2004 | 126 | 0.090 |
Why?
|
Treatment Outcome | 6 | 2021 | 63107 | 0.090 |
Why?
|
Genes, Recessive | 1 | 2012 | 641 | 0.090 |
Why?
|
Nerve Tissue Proteins | 1 | 2022 | 4463 | 0.080 |
Why?
|
Bone Marrow Cells | 1 | 2017 | 2513 | 0.080 |
Why?
|
Genetic Linkage | 2 | 2013 | 2421 | 0.080 |
Why?
|
Dietary Supplements | 2 | 2018 | 3296 | 0.080 |
Why?
|
Neoplasms, Connective Tissue | 1 | 2008 | 40 | 0.080 |
Why?
|
Diphosphonates | 2 | 2023 | 623 | 0.080 |
Why?
|
Xenopus laevis | 1 | 2012 | 957 | 0.080 |
Why?
|
Angiodysplasia | 1 | 2008 | 23 | 0.080 |
Why?
|
Hemangiopericytoma | 1 | 2008 | 77 | 0.080 |
Why?
|
Jaw Neoplasms | 1 | 2008 | 70 | 0.080 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 1995 | 1516 | 0.080 |
Why?
|
Cell Lineage | 1 | 2017 | 2504 | 0.080 |
Why?
|
Oocytes | 1 | 2012 | 1188 | 0.070 |
Why?
|
Aged | 9 | 2021 | 163288 | 0.070 |
Why?
|
Thigh | 1 | 2008 | 247 | 0.070 |
Why?
|
Leg Ulcer | 1 | 2007 | 69 | 0.070 |
Why?
|
Amino Acid Substitution | 3 | 2019 | 1793 | 0.070 |
Why?
|
Kidney Failure, Chronic | 3 | 2008 | 2535 | 0.070 |
Why?
|
Thyroid Neoplasms | 1 | 2019 | 2282 | 0.070 |
Why?
|
Mesenchymal Stem Cells | 1 | 2017 | 1632 | 0.070 |
Why?
|
Chickens | 1 | 2008 | 865 | 0.070 |
Why?
|
Nose Neoplasms | 1 | 2008 | 246 | 0.070 |
Why?
|
Models, Molecular | 2 | 2013 | 5451 | 0.070 |
Why?
|
Registries | 1 | 2021 | 8091 | 0.070 |
Why?
|
Headache | 1 | 2013 | 1226 | 0.070 |
Why?
|
Adolescent | 5 | 2014 | 85779 | 0.070 |
Why?
|
Enzyme Inhibitors | 1 | 2016 | 3799 | 0.060 |
Why?
|
Calciphylaxis | 1 | 2007 | 124 | 0.060 |
Why?
|
Diagnosis, Differential | 3 | 2014 | 12961 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4839 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2022 | 7882 | 0.060 |
Why?
|
COS Cells | 2 | 2015 | 1161 | 0.060 |
Why?
|
Calcium Channel Agonists | 1 | 2004 | 29 | 0.060 |
Why?
|
Foot | 1 | 2008 | 527 | 0.060 |
Why?
|
Kidney Diseases | 1 | 2015 | 2148 | 0.060 |
Why?
|
Genome-Wide Association Study | 2 | 2013 | 12262 | 0.060 |
Why?
|
Physicians | 1 | 2021 | 4567 | 0.060 |
Why?
|
DNA | 2 | 2014 | 7294 | 0.060 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 6489 | 0.060 |
Why?
|
Diabetic Foot | 1 | 2007 | 355 | 0.060 |
Why?
|
Osteomyelitis | 1 | 2007 | 402 | 0.050 |
Why?
|
Base Sequence | 4 | 2012 | 12797 | 0.050 |
Why?
|
Young Adult | 3 | 2013 | 56429 | 0.050 |
Why?
|
Mice, Knockout | 1 | 1997 | 14561 | 0.050 |
Why?
|
Radiography | 1 | 2013 | 7023 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2018 | 57776 | 0.050 |
Why?
|
Alendronate | 1 | 2022 | 171 | 0.050 |
Why?
|
Indocyanine Green | 1 | 2023 | 239 | 0.050 |
Why?
|
Neoplasms | 2 | 2008 | 21696 | 0.050 |
Why?
|
Quality of Life | 2 | 2022 | 12802 | 0.050 |
Why?
|
Renin | 1 | 2022 | 642 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4328 | 0.050 |
Why?
|
Receptors, Calcitriol | 1 | 2022 | 348 | 0.050 |
Why?
|
Diabetic Nephropathies | 1 | 2007 | 984 | 0.040 |
Why?
|
Sweden | 1 | 2022 | 1341 | 0.040 |
Why?
|
Acetaminophen | 1 | 2023 | 545 | 0.040 |
Why?
|
NAD | 1 | 2023 | 590 | 0.040 |
Why?
|
Glycolysis | 1 | 2023 | 829 | 0.040 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 21833 | 0.040 |
Why?
|
Receptors, Virus | 1 | 2022 | 649 | 0.040 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 1998 | 133 | 0.040 |
Why?
|
Photoaffinity Labels | 1 | 1998 | 86 | 0.040 |
Why?
|
Comorbidity | 1 | 2012 | 10388 | 0.040 |
Why?
|
Creatinine | 1 | 2023 | 1919 | 0.040 |
Why?
|
Republic of Korea | 1 | 2019 | 538 | 0.040 |
Why?
|
CHO Cells | 2 | 2016 | 1409 | 0.040 |
Why?
|
Aldosterone | 1 | 2022 | 877 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2019 | 15297 | 0.040 |
Why?
|
Hypophosphatemia | 1 | 2018 | 85 | 0.040 |
Why?
|
Mammals | 1 | 2023 | 1143 | 0.040 |
Why?
|
Imidazoles | 1 | 2023 | 1206 | 0.040 |
Why?
|
Family | 1 | 2008 | 3147 | 0.040 |
Why?
|
Protein Structure, Tertiary | 2 | 2016 | 3848 | 0.040 |
Why?
|
Down-Regulation | 2 | 1995 | 3001 | 0.040 |
Why?
|
Genetic Variation | 1 | 2012 | 6542 | 0.040 |
Why?
|
Cricetinae | 2 | 2016 | 2475 | 0.040 |
Why?
|
Genomic Imprinting | 1 | 1998 | 328 | 0.040 |
Why?
|
RNA, Messenger | 5 | 2018 | 13035 | 0.040 |
Why?
|
Peptide Fragments | 2 | 1999 | 5096 | 0.030 |
Why?
|
Thyroid Gland | 1 | 2023 | 1173 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2016 | 139 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2021 | 1461 | 0.030 |
Why?
|
Cohort Studies | 2 | 2022 | 40559 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2018 | 906 | 0.030 |
Why?
|
Binding Sites | 2 | 2016 | 6111 | 0.030 |
Why?
|
Estrogens | 1 | 2022 | 1566 | 0.030 |
Why?
|
RANK Ligand | 1 | 2017 | 326 | 0.030 |
Why?
|
Cross-Linking Reagents | 1 | 1998 | 694 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1998 | 1723 | 0.030 |
Why?
|
Chronic Disease | 2 | 2021 | 9145 | 0.030 |
Why?
|
Hyperplasia | 1 | 2018 | 1185 | 0.030 |
Why?
|
Cellulose | 1 | 1995 | 121 | 0.030 |
Why?
|
Cricetulus | 1 | 2016 | 818 | 0.030 |
Why?
|
Integrases | 1 | 2017 | 533 | 0.030 |
Why?
|
Protein Interaction Mapping | 1 | 2018 | 627 | 0.030 |
Why?
|
Adipogenesis | 1 | 2017 | 359 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2019 | 2971 | 0.030 |
Why?
|
Proteins | 2 | 1999 | 6100 | 0.030 |
Why?
|
Denmark | 1 | 2016 | 738 | 0.030 |
Why?
|
Diffusion Tensor Imaging | 1 | 2024 | 2305 | 0.030 |
Why?
|
Membranes, Artificial | 1 | 1995 | 378 | 0.030 |
Why?
|
Calcium Compounds | 1 | 2012 | 34 | 0.030 |
Why?
|
Cell Count | 1 | 2017 | 1856 | 0.030 |
Why?
|
United States | 2 | 2017 | 69872 | 0.030 |
Why?
|
Skull | 1 | 2017 | 814 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2008 | 19233 | 0.030 |
Why?
|
Sulfones | 1 | 1995 | 436 | 0.030 |
Why?
|
Mutagenesis | 1 | 2016 | 1264 | 0.030 |
Why?
|
Inpatients | 1 | 2023 | 2518 | 0.030 |
Why?
|
Genetic Engineering | 1 | 1997 | 951 | 0.020 |
Why?
|
Kidney Calculi | 1 | 2016 | 465 | 0.020 |
Why?
|
Osteoblasts | 1 | 2017 | 1166 | 0.020 |
Why?
|
Ligands | 1 | 1998 | 3282 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 1997 | 4320 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2012 | 39052 | 0.020 |
Why?
|
Atherosclerosis | 1 | 2007 | 3444 | 0.020 |
Why?
|
Prospective Studies | 3 | 2024 | 53290 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2016 | 3130 | 0.020 |
Why?
|
Phenotype | 2 | 2019 | 16367 | 0.020 |
Why?
|
Signal Transduction | 3 | 2017 | 23404 | 0.020 |
Why?
|
Protein Conformation | 1 | 1998 | 4010 | 0.020 |
Why?
|
Siblings | 1 | 2014 | 854 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 2016 | 804 | 0.020 |
Why?
|
Adipocytes | 1 | 2017 | 1185 | 0.020 |
Why?
|
Child, Preschool | 1 | 2012 | 41005 | 0.020 |
Why?
|
Ultrasonography | 2 | 2019 | 5984 | 0.020 |
Why?
|
Cataract | 1 | 2016 | 834 | 0.020 |
Why?
|
Incidence | 2 | 2019 | 20952 | 0.020 |
Why?
|
Rats | 4 | 1998 | 24252 | 0.020 |
Why?
|
Nucleic Acid Conformation | 1 | 2012 | 913 | 0.020 |
Why?
|
Child | 2 | 2014 | 77709 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6933 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2012 | 2839 | 0.020 |
Why?
|
Anaphylaxis | 1 | 1995 | 746 | 0.020 |
Why?
|
Polymers | 1 | 1995 | 1621 | 0.020 |
Why?
|
Rats, Wistar | 3 | 1996 | 1892 | 0.020 |
Why?
|
Models, Genetic | 1 | 1997 | 3493 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5717 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 9955 | 0.020 |
Why?
|
Pressure Ulcer | 1 | 2007 | 155 | 0.020 |
Why?
|
Patient Selection | 1 | 2017 | 4216 | 0.020 |
Why?
|
Disease Management | 1 | 2016 | 2460 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2017 | 3280 | 0.020 |
Why?
|
Health Status | 1 | 2018 | 4034 | 0.020 |
Why?
|
Liver | 1 | 2000 | 7475 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5181 | 0.020 |
Why?
|
Citrates | 1 | 2004 | 131 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2012 | 77460 | 0.010 |
Why?
|
Risk | 1 | 2016 | 9688 | 0.010 |
Why?
|
Cell Line | 2 | 2012 | 16000 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10259 | 0.010 |
Why?
|
Molecular Probes | 2 | 1995 | 316 | 0.010 |
Why?
|
Leg | 1 | 2007 | 1116 | 0.010 |
Why?
|
Opossums | 1 | 2001 | 106 | 0.010 |
Why?
|
Cholangiography | 1 | 2000 | 189 | 0.010 |
Why?
|
Paraneoplastic Syndromes | 1 | 2001 | 151 | 0.010 |
Why?
|
Protein Binding | 1 | 2012 | 9384 | 0.010 |
Why?
|
Bone Density | 1 | 2012 | 3468 | 0.010 |
Why?
|
Pilot Projects | 1 | 2012 | 8319 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15221 | 0.010 |
Why?
|
Bile Ducts | 1 | 2000 | 284 | 0.010 |
Why?
|
Molecular Weight | 1 | 2001 | 2255 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2008 | 21748 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 1997 | 12073 | 0.010 |
Why?
|
Lod Score | 1 | 1998 | 614 | 0.010 |
Why?
|
Ischemia | 1 | 2007 | 1907 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2001 | 1572 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2001 | 1472 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2000 | 20130 | 0.010 |
Why?
|
Obesity, Morbid | 1 | 2007 | 1213 | 0.010 |
Why?
|
Odds Ratio | 1 | 2008 | 9849 | 0.010 |
Why?
|
Hot Temperature | 1 | 2001 | 1356 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12244 | 0.010 |
Why?
|
GTP-Binding Proteins | 1 | 1998 | 970 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2008 | 12356 | 0.010 |
Why?
|
Urine | 1 | 1995 | 370 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 1995 | 1375 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2001 | 6313 | 0.010 |
Why?
|
Blood | 1 | 1995 | 598 | 0.010 |
Why?
|
Transfection | 1 | 2001 | 5895 | 0.010 |
Why?
|
Haplotypes | 1 | 1998 | 2779 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1998 | 4740 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2001 | 7721 | 0.000 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2007 | 11726 | 0.000 |
Why?
|
Risk Factors | 1 | 2008 | 72296 | 0.000 |
Why?
|